Stocksigma LogoStocksigma Logo

NATCO Pharma 43rd AGM Key Proceedings and Capital Raise Approval

NATCO Pharma held its 43rd Annual General Meeting on 30th Sep'26, considering key ordinary and special resolutions

NATCO Pharma 43rd AGM Key Proceedings and Capital Raise Approval

Natco Pharma Ltd · Annual General Meeting · 30 Sept 2026, 6:14 pm

NATCO Pharma 43rd AGM Key Proceedings and Capital Raise Approval NATCO Pharma held its 43rd Annual General Meeting on 30th Sep'26, considering key ordinary and special resolutions. The company sought approval to raise funds up to ₹2,000 crore in one or more tranches via preferential issue, rights issue, private placement, QIP, or other permissible modes. Shareholders also considered the adoption of FY25-26 audited financial statements, the confirmation of three interim dividends totaling ₹5.00 per share paid for FY25-26, and the re-appointment of Director P.S.R.K. Prasad. Combined e-voting results will be declared within two working days.

Original exchange filing (PDF)

More announcements from Natco Pharma Ltd

All Natco Pharma Ltd announcements